Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing's syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients
European Journal of Endocrinology · 03.08.2026 · 195 (2) · 250-261
DOI: 10.1093/ejendo/lvag141 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Endocrinology, online erschienen am 31.07.2026. Verfasst von Mario Detomas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, 97080 Würzburg, Germany. Hauptthemen laut MEDLINE: Machine Learning, Cushing Syndrome, Adrenocorticotropic Hormone, ACTH Syndrome, Ectopic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinician Scientist Program on Rare Important Syndromes in Endocrinology (RISE), Else Kröner-Fresenius-Stiftung & Eva Luise und Horst Köhler Stiftung, DFG German Research Foundation.
Abstract (Originalsprache)
Background
Limited availability of corticotropin-releasing hormone (CRH) currently complicates the differentiation of adrenocorticotropin (ACTH)-dependent Cushing's syndrome (CS). The diagnostic value of common screening tests in distinguishing Cushing's disease (CD) from ectopic CS (ECS) remains unclear.
Objective
To assess the diagnostic performance of screening tests, alone and in combination, in differentiating CD from ECS.
Methods
Retrospective multicenter study enrolling patients with confirmed ACTH-dependent CS and available screening tests at diagnosis. Data are expressed as multiples of upper limit of normal (×ULN). Optimal cut-offs were determined using Youden's Index. Combination with composite score models and machine learning algorithm were performed.
Results
A total of 566 patients were included (509 [90%] with CD). The optimal morning ACTH cut-off was 1.8×ULN (sensitivity 74%, specificity 77%, AUC=0.776 [CI-95% .688–.853]). 24h-urinary free cortisol (24h-UFC) showed the best performance (cut-off 5.9×ULN, sensitivity 72%, specificity 83%, AUC=0.854 [.816–.923]), followed by the 1 mg dexamethasone suppression test (12.8×ULN, sensitivity 70%, specificity 86%, AUC=.828 [.740–.906]). Using a composite score, a cut-off of 1.5 yielded 78% sensitivity and 92% specificity (AUC=0.865 [.798–.933]). Combining this score with findings derived from pituitary magnetic resonance imaging (MRI), sensitivity and specificity were 88% and 85% (AUC=0.931 [.887–.974]). Machine learning algorithm (balanced random forest) including screening tests-results yielded a sensitivity of 71% and specificity of 84% (AUC=0.853 [.741-.966]), while including the MRI-findings variant achieved a sensitivity and specificity of 76% and 91% (AUC=0.902 [.805-.999]).
Conclusion
Combining screening tests in composite scoring and machine learning differentiates subtypes of ACTH-dependent CS and offers a potential diagnostic alternative to the CRH stimulation test.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, 97080 Würzburg, Germany.
- Deptartment of Bioinformatics, University of Würzburg, Biocenter/Am Hubland, 97074 Würzburg, Germany.
- Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, 80336 Munich, Germany.
- Department of Neurosurgery, University of Tübingen, 72076 Tübingen, Germany.
- Department of Neurosurgery, Medical University of Graz, 8036 Graz, Austria.
- Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Mario Detomas, Juan P Prada Salcedo, Barbara Altieri, Isabel Stüfchen, Isabella Nasi-Kordhishti, Marco Losa, Marcus Quinkler, Otilia Kimpel, Greisa Vila, Jürgen Bernd Honegger, German Rubinstein, Martin Fassnacht, Timo Deutschbein
Förderung
- Clinician Scientist Program on Rare Important Syndromes in Endocrinology (RISE)
- Else Kröner-Fresenius-Stiftung & Eva Luise und Horst Köhler Stiftung
- DFG German Research Foundation
- European Reference Network on Rare Endocrine Conditions (Endo-ERN)
Zitieren
APA
Detomas, M., Prada Salcedo, J. P., Altieri, B., Stüfchen, I., Nasi-Kordhishti, I., Wolfsberger, S., Losa, M., Quinkler, M., Kimpel, O., Vila, G., Honegger, J. B., Rubinstein, G., Fassnacht, M., & Deutschbein, T. (2026). Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing's syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients. European Journal of Endocrinology, 195(2), 250-261. https://doi.org/10.1093/ejendo/lvag141
Vancouver
Detomas M, Prada Salcedo JP, Altieri B, Stüfchen I, Nasi-Kordhishti I, Wolfsberger S, et al. Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing's syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients. European Journal of Endocrinology. 2026;195(2):250-261. doi:10.1093/ejendo/lvag141
BibTeX
@article{Detomas2026,
author = {Detomas, Mario and Prada Salcedo, Juan P and Altieri, Barbara and Stüfchen, Isabel and Nasi-Kordhishti, Isabella and Wolfsberger, Stefan and Losa, Marco and Quinkler, Marcus and Kimpel, Otilia and Vila, Greisa and Honegger, Jürgen Bernd and Rubinstein, German and Fassnacht, Martin and Deutschbein, Timo},
title = {Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing's syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients},
journal = {European Journal of Endocrinology},
year = {2026},
volume = {195},
number = {2},
pages = {250--261},
doi = {10.1093/ejendo/lvag141}
}
EUVIMED